ABOUT VIVACY
Laboratoires VIVACY is a French manufacturer specialising in the development, production and distribution of injectable hyaluronic acid-based medical devices for Aesthetic and Anti-ageing Medicine. Since its opening, Laboratoires VIVACY has become a major player on the Medical Aesthetics market in Europe, exporting its technological know-how to more than 80 countries around the world.
VIVACY’s product portfolio includes three main brands: STYLAGE® dermal fillers, DESIRIAL® injectable intimate gels and premium dermo-cosmetics for women and men. The company also manufactures hyaluronic acid-based viscosupplements (medical devices) for ophthalmic surgery (I.SPACE®) and for the treatment of osteoarthritis (KARTILAGE®).
The company’s industrial factory is located in Archamps (France) in the dynamic region of Haute-Savoie, near the French-Swiss border. The VIVACY factory has become a prestigious research and development hub which is at the cutting edge of technology, meaning all of VIVACY’s products are exclusively made in France.
Key dates
Creation of the Laboratoires VIVACY.
First CE marking of STYLAGE® products.
First CE marking of STYLAGE® products: STYLAGE® S, STYLAGE® M, STYLAGE® L, and STYLAGE® Hydro.
Opening of the Marketing and Sales Office in Paris.
First CE marking of STYLAGE® with Lidocaïne products.
CE marking of STYLAGE® XL and the STYLAGE® products with Lidocaine: STYLAGE® Special Lips Lidocaïne, STYLAGE® S Lidocaïne and STYLAGE® M Lidocaïne. CE marking of I.SPACE®, medical device for ophthalmic use.
Launch of STYLAGE® HydroMax.
Launch of STYLAGE® HydroMax. Extension of the existing aesthetic range with an anaesthetic: STYLAGE® L Lidocaïne and STYLAGE® XL Lidocaïne.
CE marking of DESIRIAL® & KARTILAGE® ranges.
CE marking of DESIRIAL®, medical devices specifically designed to treat the female intimate area. CE marking of KARTILAGE® viscosupplements for the treatment of joint arthritis.
Launch of STYLAGE® XXL.
Launch of STYLAGE® XXL, for facial volume restoration and augmentation.
Opening of the new production site in Archamps.
Opening of the new production site in Archamps, Haute-Savoie (next to the Swiss border).
Launch of Dermo-cosmetics range
Launch of a premium dermo-cosmetics range, made from expert and innovative formulas, to preserve the youthfulness of the skin.
Opening of a subsidiary in Geneva.
Opening of a subsidiary in Geneva, VIVACY International SA.
Launch of My VIVACY and VIVACY ACADEMY
Launch of « MY VIVACY » application, an innovative traceability system based on RFID technology (Radio Frequency Identification) that allows medical practitioners to confirm the authenticity of their injectable VIVACY products. Available on Apple Store and Google Play.
Launch of www.vivacy-academy.com, an e-learning platform dedicated to medical professionals. It was developped to share different injection techniques, knowledge and experience of medical professionals.
Launch of a new-generation injection delivery system, Bi-SOFT® Injection Technology.
Launch of a new-generation injection delivery system, Bi-SOFT® Injection Technology, that provides greater precision, comfort, and control during the injection of STYLAGE® products.
*Laboratoires VIVACY (France). Optimised centre of gravity syringe. WO2018/185406 A1. 2018
Opening of London and Moscow subsidiaries
Opening of two subsidiaries in London and Moscow.
Launch of DESIRIAL® Paris Perfumes and update of dermo-cosmetics range
Extension of Archamps production site.
Opening of subsidiary in Poland.
Launch of new perfume range, DESIRIAL® Paris and the new VIVACY dermo-cosmetics range.
Launch of STYLAGE® Lips Plus and dermo-cosmetic range for men, Monsieur Skin Care®
Launch of new product for lip volume augmentation and contouring, STYLAGE® Lips Plus.
Launch of new premium dermo-cosmetics products for men, Monsieur Skin Care®
A unique technological expertise
Thanks to their unique technological expertise, Laboratoires VIVACY has achieved rapid success in the field of Aesthetic Medicine. Today, VIVACY is ranked among the World’s Top manufacturers of hyaluronic acid-based medical devices.
